**This is a 60-seconds sample of the video. For the full version, please contact us.**
U.N. facility allocates 3 mil. doses of China's vaccine to N. Korea
A U.N.-backed facility has newly allocated 3 million doses of coronavirus vaccine produced by China's major pharmaceutical company Sinovac Biotech Ltd. to North Korea, according to U.S. media. But it is uncertain whether North Korea will accept them, Radio Free Asia on Wednesday quoted an official of the World Health Organization as saying, with all eyes on when the nation will obtain vaccines for its people through the COVAX platform. North Korea may carefully consider receiving Sinovac's vaccine from the framework designed to guarantee equitable global access to coronavirus vaccines, as many countries in South America and Southeast Asia have recently started to doubt the efficacy of it. Pyongyang claims no infection cases have been found in the nation. It has cut off land traffic to and from China and Russia since early last year to prevent the intrusion of the virus, first detected in the central Chinese city of Wuhan in late 2019.
- Product Code
- ILEA000687641
- Registered date
- 2021/8/19 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media source
- Kyodo News
- Media size
- 1920 × 1080 pixel
- Deployment size
- 97.94(MB)*
- Special instruction
*File size when opened in Photoshop, etc.
